New Delhi: The Supreme Court of India has set aside criminal proceedings initiated against directors of Indica Laboratories Pvt. Ltd., holding that the complaints filed against them for allegedly selling substandard Rabeprazole tablets were barred by limitation under the Code of Criminal Procedure (CrPC).

The apex court clarified that for offenses under the Drugs and Cosmetics Act, 1940 carrying a maximum imprisonment of three years, the limitation period begins from the date of receipt of the Government Analyst’s report.

A Bench of Justice Vikram Nath and Justice Sandeep Mehta allowed the appeals filed by Miteshbhai J. Patel and another, challenging the Kerala High Court’s judgment dated December 5, 2023, which had upheld the Trial Court’s decision to continue proceedings against t

See Full Page